These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 22499579

  • 1. Moving beyond a single perfusion threshold to define penumbra: a novel probabilistic mismatch definition.
    Nagakane Y, Christensen S, Ogata T, Churilov L, Ma H, Parsons MW, Desmond PM, Levi CR, Butcher KS, Davis SM, Donnan GA, EPITHET Investigators.
    Stroke; 2012 Jun; 43(6):1548-55. PubMed ID: 22499579
    [Abstract] [Full Text] [Related]

  • 2. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue.
    Shih LC, Saver JL, Alger JR, Starkman S, Leary MC, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Villablanca JP, Vespa PM, Kidwell CS.
    Stroke; 2003 Jun; 34(6):1425-30. PubMed ID: 12738899
    [Abstract] [Full Text] [Related]

  • 3. EPITHET: Positive Result After Reanalysis Using Baseline Diffusion-Weighted Imaging/Perfusion-Weighted Imaging Co-Registration.
    Nagakane Y, Christensen S, Brekenfeld C, Ma H, Churilov L, Parsons MW, Levi CR, Butcher KS, Peeters A, Barber PA, Bladin CF, De Silva DA, Fink J, Kimber TE, Schultz DW, Muir KW, Tress BM, Desmond PM, Davis SM, Donnan GA, EPITHET Investigators.
    Stroke; 2011 Jan; 42(1):59-64. PubMed ID: 21127303
    [Abstract] [Full Text] [Related]

  • 4. Comparison of computed tomography perfusion and magnetic resonance imaging perfusion-diffusion mismatch in ischemic stroke.
    Campbell BC, Christensen S, Levi CR, Desmond PM, Donnan GA, Davis SM, Parsons MW.
    Stroke; 2012 Oct; 43(10):2648-53. PubMed ID: 22858726
    [Abstract] [Full Text] [Related]

  • 5. Refining the perfusion-diffusion mismatch hypothesis.
    Butcher KS, Parsons M, MacGregor L, Barber PA, Chalk J, Bladin C, Levi C, Kimber T, Schultz D, Fink J, Tress B, Donnan G, Davis S, EPITHET Investigators.
    Stroke; 2005 Jun; 36(6):1153-9. PubMed ID: 15914768
    [Abstract] [Full Text] [Related]

  • 6. Perfusion MR predicts outcome in high-risk transient ischemic attack/minor stroke: a derivation-validation study.
    Asdaghi N, Hill MD, Coulter JI, Butcher KS, Modi J, Qazi A, Goyal M, Demchuk AM, Coutts SB.
    Stroke; 2013 Sep; 44(9):2486-92. PubMed ID: 23908062
    [Abstract] [Full Text] [Related]

  • 7. Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction.
    Deguchi I, Takeda H, Furuya D, Dembo T, Nagoya H, Kato Y, Ito Y, Fukuoka T, Maruyama H, Tanahashi N.
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):108-13. PubMed ID: 20851627
    [Abstract] [Full Text] [Related]

  • 8. The effects of alteplase 3 to 6 hours after stroke in the EPITHET-DEFUSE combined dataset: post hoc case-control study.
    Ogata T, Christensen S, Nagakane Y, Ma H, Campbell BC, Churilov L, Lansberg MG, Straka M, De Silva DA, Mlynash M, Bammer R, Olivot JM, Desmond PM, Albers GW, Davis SM, Donnan GA, EPITHET and DEFUSE Investigators.
    Stroke; 2013 Jan; 44(1):87-93. PubMed ID: 23250996
    [Abstract] [Full Text] [Related]

  • 9. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch.
    Chemmanam T, Campbell BC, Christensen S, Nagakane Y, Desmond PM, Bladin CF, Parsons MW, Levi CR, Barber PA, Donnan GA, Davis SM, EPITHET Investigators.
    Neurology; 2010 Sep 21; 75(12):1040-7. PubMed ID: 20720188
    [Abstract] [Full Text] [Related]

  • 10. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC.
    Exp Neurol; 2008 Jul 21; 212(1):53-62. PubMed ID: 18462720
    [Abstract] [Full Text] [Related]

  • 11. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D, Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology.
    Stroke; 2003 Aug 21; 34(8):e109-37. PubMed ID: 12869717
    [Abstract] [Full Text] [Related]

  • 12. Salvage of the PWI/DWI mismatch up to 48 h from stroke onset leads to favorable clinical outcome.
    Ma H, Wright P, Allport L, Phan TG, Churilov L, Ly J, Zavala JA, Arakawa S, Campbell B, Davis SM, Donnan GA.
    Int J Stroke; 2015 Jun 21; 10(4):565-70. PubMed ID: 24612428
    [Abstract] [Full Text] [Related]

  • 13. A topographic study of the evolution of the MR DWI/PWI mismatch pattern and its clinical impact: a study by the EPITHET and DEFUSE Investigators.
    Ogata T, Nagakane Y, Christensen S, Ma H, Campbell BC, Churilov L, Olivot JM, Desmond PM, Albers GW, Davis SM, Donnan GA, EPITHET and DEFUSE Investigators.
    Stroke; 2011 Jun 21; 42(6):1596-601. PubMed ID: 21512174
    [Abstract] [Full Text] [Related]

  • 14. Effect of baseline magnetic resonance imaging (MRI) apparent diffusion coefficient lesion volume on functional outcome in ischemic stroke.
    Ma L, Gao PY, Hu QM, Lin Y, Jing LN, Xue J, Chen ZJ, Wang YJ, Liu ML, Cai YF.
    Neurol Res; 2011 Jun 21; 33(5):494-502. PubMed ID: 21669118
    [Abstract] [Full Text] [Related]

  • 15. Distance to Thrombus in Acute Middle Cerebral Artery Occlusion Predicts Target Mismatch and Ischemic Penumbra.
    Gawlitza M, Friedrich B, Hobohm C, Schaudinn A, Schob S, Quäschling U, Hoffmann KT, Lobsien D.
    J Stroke Cerebrovasc Dis; 2016 Feb 21; 25(2):298-305. PubMed ID: 26542822
    [Abstract] [Full Text] [Related]

  • 16. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
    Hougaard KD, Hjort N, Zeidler D, Sørensen L, Nørgaard A, Thomsen RB, Jonsdottir K, Mouridsen K, Hansen TM, Cho TH, Nielsen TT, Bøtker HE, Østergaard L, Andersen G.
    Int J Stroke; 2013 Feb 21; 8(2):141-6. PubMed ID: 22463392
    [Abstract] [Full Text] [Related]

  • 17. Factors that determine penumbral tissue loss in acute ischaemic stroke.
    Jung S, Gilgen M, Slotboom J, El-Koussy M, Zubler C, Kiefer C, Luedi R, Mono ML, Heldner MR, Weck A, Mordasini P, Schroth G, Mattle HP, Arnold M, Gralla J, Fischer U.
    Brain; 2013 Dec 21; 136(Pt 12):3554-60. PubMed ID: 24065722
    [Abstract] [Full Text] [Related]

  • 18. Identifying thresholds for penumbra and irreversible tissue damage.
    Heiss WD, Sobesky J, Hesselmann V.
    Stroke; 2004 Nov 21; 35(11 Suppl 1):2671-4. PubMed ID: 15459433
    [Abstract] [Full Text] [Related]

  • 19. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].
    Kakuda W, Abo M.
    Brain Nerve; 2008 Oct 21; 60(10):1173-80. PubMed ID: 18975605
    [Abstract] [Full Text] [Related]

  • 20. Optimal Tmax threshold for predicting penumbral tissue in acute stroke.
    Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, Bammer R, Marks MP, Albers GW.
    Stroke; 2009 Feb 21; 40(2):469-75. PubMed ID: 19109547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.